Healthcare / Health Information ServicesASX
$0.01
-0.00 (-12.50%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 25%
FCF escenarios
weak_data · normalized FCF $-4.6M · quality 75.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
19/100
F
Piotroski
0/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$5M
P/E
N/A
•EV/EBITDA
N/A
•ROE
179.3%
↑Gross Margin
100.0%
↑Debt/Equity
-1.41
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+2.8%
FCF CAGR
—
FCF margin
-695.6%
FCF / Net income
0.65x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $673250.0 · net income $-7.2M · FCF $-4.7M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $673250.00 | $673250.00 | $1.1M | $774260.00 | $619016.00 |
| Net Income | $-7.2M | $-7.2M | $-3.2M | $-5.0M | $-6.9M |
| EBITDA | $-5.8M | $-5.8M | $-2.5M | $-4.3M | $-6.5M |
| EPS | -0.02 | -0.02 | -0.01 | -0.02 | -0.04 |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | -1122.0% | -1122.0% | -586.5% | -948.0% | -1282.6% |
| Net Margin | -1071.3% | -1071.3% | -285.4% | -650.6% | -1122.3% |
| Balance Sheet | |||||
| Debt/Equity | -1.41 | -1.41 | -2.17 | -6.35 | 1.84 |
| Current Ratio | 0.17 | 0.17 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-4.7M | $-4.7M | $-4.2M | $-4.6M | $-6.6M |
| Returns | |||||
| ROE | 179.3% | 179.3% | 217.4% | 10749.5% | -592.0% |
| Valuation | |||||
| P/B | — | — | — | — | 6.77 |
| Growth & Yield | |||||
| Revenue Growth | -40.0% | -40.0% | 45.0% | 25.1% | — |
| EPS Growth | -69.6% | -69.6% | 62.9% | 32.8% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-64.1%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.01 → -0.02
Residual
-64.1%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.